UKBizDB.co.uk

CHAMPIONS ONCOLOGY UK LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Champions Oncology Uk Limited. The company was founded 16 years ago and was given the registration number 06861239. The firm's registered office is in LONDON. You can find them at Suite 1, 3rd Floor, 11-12 St. James’s Square, London, . This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:CHAMPIONS ONCOLOGY UK LIMITED
Company Number:06861239
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:27 March 2009
End of financial year:30 April 2023
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:Suite 1, 3rd Floor, 11-12 St. James’s Square, London, United Kingdom, SW1Y 4LB
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
First Floor, Templeback, 10 Temple Back, Bristol, BS1 6FL

Corporate Secretary27 March 2010Active
First Floor, Templeback, 10 Temple Back, Bristol, United Kingdom, BS1 6FL

Director06 April 2011Active
First Floor, Templeback, 10 Temple Back, Bristol, United Kingdom, BS1 6FL

Director08 February 2010Active
Summit House, 12 Red Lion Square, London, United Kingdom, WC1R 4QD

Director27 March 2009Active
1, Mitchell Lane, Bristol, United Kingdom, BS1 6BU

Director27 March 2009Active
Summit House, 12 Red Lion Square, London, United Kingdom, WC1R 4QD

Director27 March 2009Active

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (5 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (7 months remaining)

Copyright © 2025. All rights reserved.